Published in Neuropsychopharmacology on October 19, 2011
Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74
PharmGKB summary: caffeine pathway. Pharmacogenet Genomics (2012) 0.86
Contextual fear conditioning in virtual reality is affected by 5HTTLPR and NPSR1 polymorphisms: effects on fear-potentiated startle. Front Behav Neurosci (2013) 0.86
Affect-modulated startle: interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma. PLoS One (2012) 0.79
Multilevel impact of the dopamine system on the emotion-potentiated startle reflex. Psychopharmacology (Berl) (2014) 0.77
GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder. Mol Psychiatry (2017) 0.76
Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation. Psychopharmacology (Berl) (2012) 0.76
Emotional processing and rTMS: does inhibitory theta burst stimulation affect the human startle reflex? J Neural Transm (Vienna) (2016) 0.76
Is prepulse modification altered by continuous theta burst stimulation? DAT1 genotype and motor threshold interact on prepulse modification following brain stimulation. Eur Arch Psychiatry Clin Neurosci (2017) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry (2003) 21.70
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther (1986) 8.33
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet (2003) 4.63
A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry (2001) 4.55
Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol (2005) 4.50
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A (2003) 4.21
Committee report: Guidelines for human startle eyeblink electromyographic studies. Psychophysiology (2005) 3.78
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature (1997) 3.75
The neurobiology of startle. Prog Neurobiol (1999) 3.60
A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol (2003) 2.91
The endophenotype concept in psychiatric genetics. Psychol Med (2006) 2.49
Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology. Biol Psychiatry (2002) 2.49
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci (2005) 2.34
Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology (Berl) (2007) 2.18
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2003) 1.65
Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry (1998) 1.62
The cross-national epidemiology of panic disorder. Arch Gen Psychiatry (1997) 1.61
Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry (1994) 1.49
Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav (2007) 1.48
A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther (2007) 1.40
Functional neuroanatomy of anxiety: a neural circuit perspective. Curr Top Behav Neurosci (2010) 1.36
Effects of picture content and intensity on affective physiological response. Psychophysiology (2006) 1.36
The psychological significance of human startle eyeblink modification: a review. Biol Psychol (1998) 1.33
Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr (2007) 1.32
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2008) 1.31
Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology (Berl) (1988) 1.31
Enhanced drug metabolism in cigarette smokers. Br Med J (1976) 1.31
The effect of gonadal hormones and gender on anxiety and emotional learning. Horm Behav (2006) 1.29
Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl) (2010) 1.27
Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Neuropsychopharmacology (2008) 1.26
Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry (1990) 1.21
Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet (2007) 1.21
Animal studies of amygdala function in fear and uncertainty: relevance to human research. Biol Psychol (2006) 1.16
Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology (2010) 1.16
Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis. Prog Neurobiol (2009) 1.15
Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol (2005) 1.15
Anxiogenic action of caffeine: an experimental study in rats. J Psychopharmacol (1997) 1.13
Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol (2004) 1.12
Fearfulness and startle potentiation during aversive visual stimuli. Psychophysiology (1992) 1.11
Oral contraceptives and panic disorder. J Clin Psychiatry (1992) 1.08
Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. Am J Psychiatry (1999) 1.08
Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology (2004) 1.08
Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry (1985) 1.07
Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry (1998) 1.07
Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Arch Gen Psychiatry (1999) 1.06
Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am J Med Genet B Neuropsychiatr Genet (2005) 1.04
Imaging genetics of anxiety disorders. Neuroimage (2009) 1.00
Threat is in the eye of the beholder: social anxiety and the interpretation of ambiguous facial expressions. Behav Res Ther (2006) 0.99
Phylo- and ontogenetic fears and the expectation of danger: differences between spider- and flight-phobic subjects in cognitive and physiological responses to disorder-specific stimuli. J Abnorm Psychol (2006) 0.98
[The German short version of "Profile of Mood States" (POMS): psychometric evaluation in a representative sample]. Psychother Psychosom Med Psychol (2005) 0.98
Virtual reality for the psychophysiological assessment of phobic fear: responses during virtual tunnel driving. Psychol Assess (2007) 0.95
Darkness-enhanced startle responses in ecologically valid environments: a virtual tunnel driving experiment. Biol Psychol (2007) 0.95
Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. Arch Gen Psychiatry (1984) 0.92
Affective information processing and the assessment of anxiety. J Behav Assess (1984) 0.92
Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res (2010) 0.91
Adenosine A(2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder. Eur Child Adolesc Psychiatry (2009) 0.90
Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats. Behav Pharmacol (1999) 0.87
Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res (2008) 0.86
Influence of functional tryptophan hydroxylase 2 gene variation and sex on the startle response in children, young adults, and older adults. Biol Psychol (2010) 0.85
Caffeine challenge test in panic disorder and depression with panic attacks. Compr Psychiatry (2007) 0.84
Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res (2009) 0.84
Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev (2011) 0.84
Affect-modulated startle reflex and dopamine D4 receptor gene variation. Psychophysiology (2009) 0.84
Covariation bias in panic-prone individuals. J Abnorm Psychol (1996) 0.83
Gender differences in the etiology of anxiety sensitivity: a twin study. J Gend Specif Med (2001) 0.83
Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet (2008) 0.83
Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci Lett (2004) 0.83
Anxiogenic effects of caffeine in patients with anxiety disorders. Arch Gen Psychiatry (1992) 0.83
Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm (Vienna) (2001) 0.82
Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues. Behav Pharmacol (1991) 0.81
The effects of different doses of caffeine on habituation of the human acoustic startle reflex. Pharmacol Biochem Behav (1995) 0.80
Genetics of panic disorder: focus on association studies and therapeutic perspectives. Expert Rev Neurother (2010) 0.80
A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls. Depress Anxiety (2008) 0.80
Structure-related inhibition of human hepatic caffeine N3-demethylation by naturally occurring flavonoids. Biochem Pharmacol (1998) 0.80
Anxiety and mood disorders in children and adolescents: A practice update. Paediatr Child Health (2001) 0.80
Affective modulation and prepulse inhibition of startle among undergraduates high and low in behavioral inhibition and approach. Psychophysiology (2003) 0.79
Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.79
Interactions between chronic stress and chronic consumption of caffeine on the enzymatic antioxidant system. Neurochem Res (2009) 0.79
Coffee increases state anxiety in males but not in females. Hum Psychopharmacol (2003) 0.79
Sympathetic activity relates to adenosine A(2A) receptor gene variation in blood-injury phobia. J Neural Transm (Vienna) (2008) 0.78
Dose-response effects of intravenous caffeine in normal volunteers. Anxiety (1997) 0.78
Neonatal caffeine alters passive avoidance retention in rats in an age- and gender-related manner. Brain Res Dev Brain Res (1997) 0.78
Effects of caffeine and caffeine-associated stimuli on the human startle eyeblink reflex. Pharmacol Biochem Behav (1998) 0.77
A case of panic disorder induced by oral contraceptive. Acta Obstet Gynecol Scand (1992) 0.77
The adenosine A(2A) receptor knockout mouse: a model for anxiety? Int J Neuropsychopharmacol (1998) 0.77
Caffeine abstention in the management of anxiety disorders. Psychol Med (1989) 0.76
Anxiety and the processing of emotional information. Prog Exp Pers Psychopathol Res (1993) 0.76
Caffeine reduction as an adjunct to anxiety management. Br J Clin Psychol (1988) 0.76
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71
Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol Psychiatry (2011) 2.60
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48
Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna) (2008) 2.43
Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One (2009) 2.37
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest (2004) 2.36
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain (2010) 2.35
Neural correlates of epigenesis. Proc Natl Acad Sci U S A (2006) 2.24
Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2008) 2.04
Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression. Psychoneuroendocrinology (2012) 1.99
High impact running improves learning. Neurobiol Learn Mem (2006) 1.88
HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis (2002) 1.87
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
S100B in brain damage and neurodegeneration. Microsc Res Tech (2003) 1.85
Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology (2005) 1.79
Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. Am J Psychiatry (2013) 1.71
Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol Psychiatry (2012) 1.70
Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects. Neuropsychopharmacology (2013) 1.67
Automatic mood-congruent amygdala responses to masked facial expressions in major depression. Biol Psychiatry (2010) 1.66
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2003) 1.65
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
High phosphate directly affects endothelial function by downregulating annexin II. Kidney Int (2012) 1.57
Neural activation underlying acute grief in women after the loss of an unborn child. Am J Psychiatry (2009) 1.52
Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol (2006) 1.51
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.48
Diagnosing delirium in older hospitalized adults with dementia: adapting the confusion assessment method to international classification of diseases, tenth revision, diagnostic criteria. J Am Geriatr Soc (2012) 1.48
Acceptance of medical training cases as supplement to lectures. GMS Z Med Ausbild (2011) 1.47
5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology (2007) 1.44
Modulation of event-related brain potentials during affective picture processing: a complement to startle reflex and skin conductance response? Int J Psychophysiol (2004) 1.44
Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients. Atherosclerosis (2013) 1.41
Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res (2003) 1.39
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. J Clin Psychiatry (2015) 1.39
Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J Neural Transm (Vienna) (2008) 1.36
Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology (2009) 1.33
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2008) 1.31
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis (2003) 1.28
Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: a 3 T fMRI study. J Psychiatry Neurosci (2007) 1.22
Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J Psychiatr Res (2006) 1.22
Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol (2009) 1.21
Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet (2007) 1.21
Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J Cereb Blood Flow Metab (2002) 1.20
Electromyographic responses to static and dynamic avatar emotional facial expressions. Psychophysiology (2006) 1.20
Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res (2006) 1.19
Early cortical processing of natural and artificial emotional faces differs between lower and higher socially anxious persons. J Neural Transm (Vienna) (2008) 1.19
Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int J Neuropsychopharmacol (2008) 1.18
A rift between implicit and explicit conditioned valence in human pain relief learning. Proc Biol Sci (2010) 1.18
Role of endogenous testosterone concentration in pediatric stroke. Ann Neurol (2009) 1.17
Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci (2003) 1.17
Amygdala reactivity predicts automatic negative evaluations for facial emotions. Psychiatry Res (2006) 1.16
Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology (2010) 1.16
Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology (Berl) (2003) 1.15
Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol (2005) 1.15
Is eye to eye contact really threatening and avoided in social anxiety?--An eye-tracking and psychophysiology study. J Anxiety Disord (2008) 1.14
Impact of working memory load on FMRI resting state pattern in subsequent resting phases. PLoS One (2009) 1.14
Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology (2006) 1.14
Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. Cereb Cortex (2006) 1.14
A molecular signature in blood identifies early Parkinson's disease. Mol Neurodegener (2012) 1.13
Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology (2007) 1.13
Childhood maltreatment is associated with an automatic negative emotion processing bias in the amygdala. Hum Brain Mapp (2012) 1.12
Fear of negative evaluation and the hypervigilance-avoidance hypothesis: an eye-tracking study. J Neural Transm (Vienna) (2008) 1.12
Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol (2004) 1.12
Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail (2007) 1.12
Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet (2013) 1.11
Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatr Genet (2010) 1.11
High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry (2013) 1.10
Pain-relief learning in flies, rats, and man: basic research and applied perspectives. Learn Mem (2014) 1.09
Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 1.09
Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord (2005) 1.09
Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol (2005) 1.08
Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry (2003) 1.08
Don't look at me in anger! Enhanced processing of angry faces in anticipation of public speaking. Psychophysiology (2009) 1.08
Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry (2004) 1.08
Aneurysm of the petrous portion of the internal carotid artery at the foramen lacerum: anatomic, imaging, and otologic findings. Ear Nose Throat J (2010) 1.08
Reduced lateral prefrontal activation in adult patients with attention-deficit/hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (fNIRS) study. J Psychiatr Res (2008) 1.08
Increased amygdala activation during automatic processing of facial emotion in schizophrenia. Psychiatry Res (2010) 1.08
Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology (2011) 1.07
Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder. Hum Brain Mapp (2009) 1.06